Status:
COMPLETED
Efficacy Study of Two Choices of Phototherapy on Itching Skin Diseases
Lead Sponsor:
University of Zurich
Conditions:
Eczema
Psoriasis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This is a double-blind prospective randomized monocenter study comparing the efficacy of two phototherapy ultraviolet spectra on pruritus (itching) of inflammatory skin diseases. 40 patients per treat...
Detailed Description
In patients with a skin disease and the given indication for a phototherapy with Ultraviolet B narrow-band (UVB narrowband, 311nm) with or without Ultraviolet A (UVA, 320-400 nm), the subjective pruri...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- Pruritic inflammatory diseases such as atopic dermatitis, other types of eczema, psoriasis, prurigo simplex subacuta and others.
- Main inclusion criteria:
- Pruritus VAS Score 5 or higher at screening.
- Dermatological indication for a phototherapy with UVB nb / UVA
- Oral and written informed patient consent
- Exclusion criteria:
- \- Patients will be excluded from the study if they fulfill any of the following criteria:
- Foreseeable interruption of the light therapy for more than 14 days, or interruption of the light therapy for more than 14 days during the study
- Heightened photosensitivity for UVA or UVB
- Withdrawal of consent to participate
- Concomitant participation in another study or having taken part in another clinical study within the last 30 days.
Exclusion
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01254240
Start Date
December 1 2010
End Date
December 1 2015
Last Update
May 12 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich, Department of Dermatology
Zurich, Switzerland, 8091